Latest News and Press Releases

Article Indicates that Inhibition of PP2A Enhances Immunotherapy Responsewith LIXTE’s Proprietary Compound LB100 PASADENA, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings,...

ROCKVILLE, Md., July 09, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery,...

Preferred NextGen Leadership Council Celebrates Milestone First Year, Uniting Tomorrow’s Stars of the MICE Industry

NEEDHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...

Highlights High Light Rare Earths Leach Recoveries Praseodymium (“Pr”) leach recoveries of 85% at optimal conditionsNeodymium (“Nd”) leach recoveries of 84% at optimal conditions Encouraging Heavy...

Nonprofit organization enhances international COVID response efforts with new compliance and quality assurance measures.

Custom-built model will be trained using Revolution Medicines’ proprietary data to discover novel drug candidatesIambic to receive up to $25 million through a combination of upfront and expected...

Chicago-based physician to contribute through Anosh Inc Foundation and host local fundraiser in support of federal agents

Reducing workforce by approximately 50% to focus on Chronic Urticaria programs and extend cash runway Dr. Edwin Tucker departing as Chief Medical Officer; Dr. Daniel Adelman to serve as Acting Chief...

RESTON, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), a leader in advanced nuclear fuel technology, today announced that management will participate in the following...